Member Info for Fevertreeman

Massively unimpressed by the performance of our BoD. which is being reflected in the relentless drift south of the share price. What on earth are they playing at? TPelham as CEO barely last 8 months, and since he was defenstrated (Oct 2021) we have been promised a new CEO before year end which is only 8 weeks away....8 months on from appointing h/hunters we still have no CEO. Meanwhile Page announces an expensive strategic review in January, and guess what 6 months on, still no substantive announcements beyond meaningless platitudes in April that had no substance....appointing a new NED seems to have been the only thing the Board has accomplished since January

1. Appoint & then dis-appoint CEO w/i space of a relatively short time
2. Announce to great fanfare a strategic review. And still no results despite spending 000s of thousands on advisers. Hone20 year old doing a business studies degree could have come up with a viable plan in the space this month has taken not to come up with the reviews results
3. And still no new CEO….not a surprise really as n/o in their right mind would take on the role not knowing what sort of business he was joining, and still none the wiser
Verdict this is a bloody shambles and the sp has gone nowhere for years as the board has not been under any pressure to deliver

Cant answer that but makes sense -IPO market and new debt raising in USA has fallen off cliff...not a surprise

Good questionrs regarding how much new equity AN can/should raise (and from where). It all depends on the business plan - how quickly they can ramp up etc....so I can't answer that

In terms of if AN goes for a Nasdaq listing I think the steps could be as follows:
1. Initially Angle may keep the UK listing (to keep s/holders happy here and provide liquidity) and launches an IPO on Nasdaq to achieve a dual listing London/USA. The likely outcome is that (1) liquidity in terms of trading of AGL shares gets a significant boost from US holders trading the ADRs (2) Share price increases driven by US investors (3) There's a rapid increase in % of AGL shares held on Nasdaq which becomes the driver for share performance to the point where most of the trading takes place stateside reducing liquidiy on London exchange.

2. Angle may well decide to go the whole hog and cancel London listing because (1) liquidity in London is poor (2) Expensive & onerous to maintain dual listing (3) Most trading now taking place in different time zone. The argument will be that combining share volumes onto Nasdaq exchange benefits all shareholders and UK shareholders can still access the shares. As its an AIM company, it may well require a shareholder vote which will require a circular sent round to s/holders etc but I am a bit hazy on this

There is a lead-in period during which the shares will still trade on AIM. UK shareholders will be given teh option to convert their Angle Ord shares into Angle ADRs (trading on Nasdaq). American normally like big figures for their shares so for example 10:1 conversion would see 10 Ordinary bundled into 1 ADr share i.e 1 ADR of £14. Once the conversion takes place one can trade the stock as per normal except on Nasdaq. Unsure of what the tax implications are etc...

I have been a long term holder since 2015, doing some buying and selling along the way, but kept faith in Newland (contemporary at university). Finally, now we have genuinely something to shout about after years of endless delays etc.
Having worked in pharma industry, and as a city insider, I would make the following observations about comments on teh way forward posted here and on other sites:

1. AN will be fully aware that they need to move projects along quickly & start capitalising on the FDA approval....that will require a much bigger infrastructure with all the associated costs
2. M&A and prospect of Angle getting taken over: a distinct possibility given teh game-changing nature of what AN and the team have achieved.....on Abbott which comes up a lot...Abbott's reputation and leadership are really under the cosh in US because of a contaminated baby milk scandal which is fast becoming a reputational disaster for them -they have their hands full fighting fires there. And remember these behemoths move very slowly when it comes to M&A transactions...so I think there is plenty of runway left for AN to grow the company, build capabilities & grow revenues and profits....but that will take cash and lots of it....so yes he needs to raise more cash to improve his negotiating position and turbo charge the business expansion....
3. UK investors as usual have sod all idea of how to value this sort of company. My experience is that they pay scant attention to game-changing businesses like this till it's too late and they have been snapped up (GW Pharma etc). There isnt the expertise or deep pools of capital here to back this sort of company and AN knows this only too well. Risk appetite in Europe is woeful.
4. Jefferies appointment was in my view expressly to get cracking on a NASDAQ listing (post successful FDA). With the FDA approval, AN will be welcomed with open arms by US investors who recognise what is needed to get these companies to grow quickly, understand the sector, and are prepared to throw large amounts of cash at a company like this at much higher valuation.
5. What does this mean? Well either AN goes for dual listing UK/Nasdaq (doable but costly in time and money satisfying both sets of shareholders), or AN decides to cancel listing here and go to Nasdaq. That will be a controversial decision given he knows full well the backing he has got from UK investors and medical community here etc...but he will know full well that the capital pools needed to fund rapid development of Angle are in the US not here sadly..and if he wants to stay independent for as long as possible, that's his best route. The fact that he in the US obn the day FDA announcement broke was no coincidence and speaks volumes....
6. What are UK investors to do?If you recognise Angle's dilemma but have faith that AN has the skills to grow this company and persuade US investors to back him big time, then I think you back him with every spare cent you have

Admas is like Edward Lear...he sputs total nonsense....this could have been said by him at any time in the last god knows how many years and counting. To call this investable is farcical. It is a punt - you might as well go to Rank casinos and bet all on red or black.

based on his ability to spend other people's money like water for years, convince folk that black is white, and egregiously enrich himself

Its quite simple. Adfams is a 24-carat, copper-bottomed, unprincipled Walter Mitty whose main interest is lying through his teeeth inorder to fund his lifestyle. None of his promises have been kept for years; he front ran the sp and then slugged s/holders with another equity raise having sworn blind it wasnt needed. The project funding is still 30pc light in terms of committed funding, and if you recycle his statements from 3-4 years ago , you'll see the same nonosense spouted about on the ground progress

And nms is 500,000 - the mm will not want to get stuck with this on their books for long, knowing HAA's awful reputation....hence it could take foever to make a decent return as the moment the sp moves there will be a tsunami of selling

Hmmmm

Exactly echoed my thoughts. Absolutely clear that this charlatan no further closing institutional financing, so another desperate move to keep the lights on. With billions of shares now in issue, the share price is marooned for years in my view as the selling pressure will come on pretty quickly the moment the thing moves. I also feel we're close to the point that the Ethiopians realise that their coveted mine isnt getting started with this clown in charge and revoke the license and hand it to a more competent player

Wouldnt be surprised if the surveillance team at London Stock Exchange haven't picked up the phone to Pinocchio given the blatant front-running before the raise. What th

this is a mining concept and has been for last decade; Harry doesnt have a mining company

We know that dont we - there is no friggin mine. The charlatan has so far shown photos of some desultory handmade ditch digging (no machines), some mud huts, a few smiling faces and that folks is it!

its incredible - market makers will have huge spreads and it will be impossible for this to lift off due to the sheer weight of paper the bastard has issued

Exactly correct. Scandalous - the obvious front-running of recent weeks is an outrage from the king of liars

Difference is that Jubilee actually is producing stuff....Pincchio has been at this for years and all we have to show for his outrageous incompetence is some photos of locals digging trenches , a few mud huts, and his swelling bank balance conveniently paid through his consulting firm in Cyprus. He is w/o doubt one of the least trustworthy individuals I have had the displeasure of meeting.

So the Ethiopians haven't signed the deal then and the financing is still not in place. The behaviour of Angostura Bitters is scandalous & perilously close to being s/thing the LSE should sanction. Harry front ran the share price for the last few weeks, with yet more rose-tinted announcements purely to raise more £ knowing that he was going to dump millions more shares onto his equity base. He is utterly unfit to be the Chair or CEO. Time that the Stock Exchange did something.

Pinocchio has been saying that for years, and banking his big consulting fees....this is stash on black or red ....better odds of success in Evraz or Polymetal!

totally agree...........nothing of substance. The charlatan continues

Proven gold reserves and a huge dollar dividend and a business that has crashed like crazy versus the blue chip that is Kefi?